ClinConnect ClinConnect Logo
Search / Trial NCT04595422

Educating Smokers About Lung Cancer Screening Using Tobacco Quitlines

Launched by M.D. ANDERSON CANCER CENTER · Oct 19, 2020

Trial Information

Current as of July 22, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how to better inform heavy smokers about lung cancer screening. The goal is to find the most effective ways to refer people who call quitlines—telephone services that help people stop smoking—to information about getting screened for lung cancer. This is important because early detection of lung cancer can lead to better treatment outcomes.

To participate in this study, you need to be a caller to the quitline who is between 55 and 80 years old, currently smoking or a former smoker who quit less than 15 years ago, and have a significant smoking history (at least 30 pack-years, which means smoking one pack a day for 30 years). You should also be comfortable speaking English. If you have a history of lung cancer, you won't be eligible for this trial. If you participate, you can expect to be involved in discussions that help improve the way smokers receive information about lung cancer screening. The study is currently recruiting participants, so there’s an opportunity to contribute to this important research.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • QUITLINE CALL CENTER STAFF
  • Staff member of a quitline
  • Aged 18 years and above
  • CALLERS (SMOKERS WHO CONTACT THE QUITLINE ABOUT SMOKING CESSATION SERVICES) INCLUSION CRITERIA
  • Callers 55-80 years of age
  • Current smoker, or former smoker with a cessation history of \< 15 years
  • \>= 30 pack-year smoking history
  • English-speaking
  • Exclusion Criteria:
  • CALLERS (SMOKERS WHO CONTACT THE QUITLINE ABOUT SMOKING CESSATION SERVICES) EXCLUSION CRITERIA
  • History of lung cancer by self-report

About M.D. Anderson Cancer Center

The University of Texas MD Anderson Cancer Center is a leading institution dedicated to cancer care, research, education, and prevention. As one of the world’s most respected cancer centers, MD Anderson focuses on innovative treatment approaches and groundbreaking clinical trials aimed at improving patient outcomes. With a multidisciplinary team of experts and state-of-the-art facilities, the center is committed to advancing cancer research and providing comprehensive, personalized care to patients. MD Anderson's clinical trials play a pivotal role in translating scientific discoveries into effective therapies, positioning the center at the forefront of cancer treatment and research.

Locations

Houston, Texas, United States

Patients applied

0 patients applied

Trial Officials

Robert J Volk

Principal Investigator

M.D. Anderson Cancer Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials